In an effort to lower the cost of necessary drugs, Aurolab created its Pharma Division in 1997 with the goal of becoming a constant and consistent source of high quality ophthalmic pharmaceuticals.
Aurolab has developed a wide range of ophthalmic drugs that are cost effective, especially in developing countries. The modern state-of-the-art pharmaceutical formulation facility produces Eye Drops, Retinal products, Viscoelastics, Ophthalmic Dyes and Antiseptics and Disinfectants.
Aurolab has received the prestigious CE mark certification for HPMC and Trypan Blue, Perfluoro-n-octane, Silicon Oil and Brilliant Blue G. The World Health Organization (WHO) Good Manufacturing Practices (GMP) certification was awarded to the division, confirming that all AUROLAB pharmaceutical products are made in compliance with international standards. |
